Clinical Research Directory
Browse clinical research sites, groups, and studies.
Spirulina Oral Supplement for Enhancing Host Resilience to Virus Infection
Sponsor: University of Mississippi Medical Center
Summary
This randomized, double blind, placebo controlled study aims to establish the impact of the oral supplement, Immulina TM, on enhancing host resilience to the effects of viral influenza infection in humans.
Official title: Impact of Oral Immulina TM on Natural Killer Cell Activities and Other Biomarkers Associated With Increasing Host Immune Resilience to Upper Respiratory Viruses in Normal Human Volunteers
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
492
Start Date
2022-07-01
Completion Date
2025-12-08
Last Updated
2026-07-30
Healthy Volunteers
Yes
Conditions
Interventions
Immulina TM
Immulina TM is a highly standardized extract derived from various preparations of Spirulina, a cyanobacterium, marketed as a dietary supplement and has been utilized in several clinical studies describing its immunopotentiating properties.
Placebo
Placebo is inert powder in cellulose capsule that appears identical to Immulina TM capsules.
Locations (1)
University of Mississippi Medical Center
Jackson, Mississippi, United States